Latest data on long-term, real-world treatment with lecanemab will be presented at the AD/PD™ 2026 congress
STOCKHOLM, March 11, 2026 /PRNewswire/ — BioArctic’s AB (publ) (STOCKHOLM: BIOA B) partner Eisai announced today that they will present…
Read More











